Revium Rx (RVRC) Accounts Payables (2024 - 2025)

Revium Rx (RVRC) reported Accounts Payables of $163000.0 for Q4 2025, up 14.79% on a YoY basis from $142000.0 in Q4 2024, and up 14.79% sequentially from $142000.0 in Q4 2024.

Revium Rx (RVRC) Accounts Payables (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Accounts Payables data on file, last reported at $163000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 14.79% year-over-year to $163000.0; the trailing twelve-month figure through Dec 2025 stood at $163000.0 (up 14.79% YoY), and the FY2025 full-year result was $163000.0, up 14.79% from the prior year.
  • Accounts Payables grew to $163000.0 in Q4 2025, from $142000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $163000.0 in Q4 2025 to a low of $142000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Veeva Systems 31.72 Bn 24.41 Bn 662.02 Mn 40.66 Mn
2 BrightSpring Health Services 14.65 Bn 13.75 Bn 482.22 Mn 1.09 Bn
3 Healthequity 8.27 Bn 8.00 Bn 256.31 Mn 14.22 Mn
4 10x Genomics 5.90 Bn 5.36 Bn 106.18 Mn 17.43 Mn
5 Hinge Health 5.88 Bn 5.56 Bn 154.23 Mn 69.48 Mn
6 MiniMed 4.53 Bn 4.23 Bn 480.00 Mn 163.00 Mn
7 Waystar Holding 4.44 Bn 4.38 Bn 216.84 Mn 58.80 Mn
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn 4.01 Mn
9 Privia Health 3.16 Bn 2.74 Bn - 80.56 Mn
10 Revium Rx 101.42 Mn 98.71 Mn - 163,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 163,000.00
Dec 31, 2024 142,000.00